Molecular prenatal diagnosis of alpha and beta thalassemia in pregnant Hakka women in southern China

• Published in: Journal of clinical laboratory analysis 2018-03, Vol.32 (3), p.n/a
• Main Authors: Zhao, Pingsen, Wu, Heming, Zhong, Zhixiong, Lan, Liubing, Zeng, Mei, Lin, Hualan, Wang, Huaxian, Zheng, Zhiyuan, Su, Luxian, Guo, Wei
• Format: Article
• Language: English
• Subjects: alpha-Thalassemia - diagnosis; alpha-Thalassemia - genetics; Amniotic fluid; beta-Thalassemia - diagnosis; beta-Thalassemia - genetics; China; Cord blood; Deoxyribonucleic acid; DNA; DNA Mutational Analysis; Edema; Female; Fetus - cytology; Fetuses; Genetic counseling; genetic mutations; Hakka women; Heterozygotes; Humans; Hybridization; Molecular Diagnostic Techniques - methods; Mutation; Peripheral blood; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Hematologic - diagnosis; Pregnancy Complications, Hematologic - genetics; pregnant women; Prenatal development; Prenatal diagnosis; Prenatal Diagnosis - methods; Retrospective Studies; southern China; Thalassemia; Villus
• ISSN: 0887-8013; 1098-2825
• DOI: 10.1002/jcla.22306

Background To date, there has been no systematic study of DNA‐based prenatal diagnosis of thalassemia in pregnant Hakka women in southern China. Methods A total of 279 pregnant Hakka women with confirmed cases of thalassemia who had been treated at the Meizhou People's Hospital in China's Guangdong Province from January 2014 to December 2016 were here enrolled. Genomic DNA was extracted from peripheral blood of couples and villus, amniotic fluid, or fetal cord blood. DNA‐based diagnosis was performed on the tissues of fetuses whose parents had tested positive for α‐ and β‐globin gene mutations were found using polymerase chain reaction (PCR) and flow‐through hybridization technique. Follow‐up visits were performed 6 months after the fetuses were born. Prenatal diagnosis was performed on 279 fetuses in at‐risk pregnancies. Results Here, 211 α‐thalassemia fetuses were confirmed, including 41 (19.43%) that tested positive for Bart's hydrops syndrome and 15 (7.11%) for Hb H disease. There were 103 (48.81%) heterozygotes. β‐thalassemia was confirmed in 68 fetuses, including 23 (33.82%) with severe thalassemia and 27 (39.71%) heterozygotes. Another 12 cases were confirmed with α+β‐thalassemia, including three cases of severe β‐thalassemia. DNA‐based testing prenatal diagnosis of thalassemia was found to be highly reliable. Conclusions Our findings provide key information for clinical genetic counseling of prenatal diagnosis for major thalassemia in pregnant Hakka women in southern China.